Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Beatty

Showing results (291-300 of 367) with videos related to

Pageof 37
Sort By:
Cancer Immunology Research|March 1, 2014
Mesothelin-specific chimeric antigen receptor mRNA-engineered T cells induce anti-tumor activity in solid malignanciesGregory L Beatty, Andrew R Haas, Marcela V Maus, et al.
Journal of Racial and Ethnic Health Disparities|March 28, 2019
Multiple Influences on Cognitive Function Among Urban-Dwelling African AmericansR S Wright, S R Waldstein, C S Gerassimakis, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 27, 2011
Binding of Plasmodium merozoite proteins RON2 and AMA1 triggers commitment to invasionPrakash Srinivasan, Wandy L Beatty, Ababacar Diouf, et al.
JMIR Cancer|June 1, 2023
Engaging Men of Diverse Racial and Ethnic Groups With Advanced Prostate Cancer in the Design of an mHealth Diet and Exercise Intervention: Focus Group StudyElizabeth Y Wang, Hala T Borno, Samuel L Washington Iii, et al.
Cell|January 24, 2012
EMT and dissemination precede pancreatic tumor formationAndrew D Rhim, Emily T Mirek, Nicole M Aiello, et al.
Journal of Virology|February 10, 2017
A Murine Herpesvirus Closely Related to Ubiquitous Human Herpesviruses Causes T-Cell DepletionSwapneel J Patel, Guoyan Zhao, Vinay R Penna, et al.
Scientific Reports|January 31, 2026
Sequential platinum and PARP Inhibition enhances PD1 immunotherapy efficacy in murine Brca2 mutated pancreatic cancerJohn C McVey, Max M Wattenberg, Heather Coho, et al.
Cancer Immunology Research|May 4, 2022
Immunologic Features in De Novo and Recurrent Glioblastoma Are Associated with Survival OutcomesCécile Alanio, Zev A Binder, Renee B Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2023
Treatment Response in First-Line Metastatic Pancreatic Ductal Adenocarcinoma Is Stratified By a Composite Index of Tumor Proliferation and CD8 T-Cell InfiltrationGregory L Beatty, Devora Delman, Jiayi Yu, et al.
The Oncologist|September 26, 2022
Epacadostat Plus Pembrolizumab and Chemotherapy for Advanced Solid Tumors: Results from the Phase I/II ECHO-207/KEYNOTE-723 StudyJohn D Powderly, Samuel J Klempner, Aung Naing, et al.
Pageof 37

Showing results (291-300 of 367) with videos related to

Sort By:
Pageof 37
Cancer Immunology Research|March 1, 2014
Mesothelin-specific chimeric antigen receptor mRNA-engineered T cells induce anti-tumor activity in solid malignanciesGregory L Beatty, Andrew R Haas, Marcela V Maus, et al.
Journal of Racial and Ethnic Health Disparities|March 28, 2019
Multiple Influences on Cognitive Function Among Urban-Dwelling African AmericansR S Wright, S R Waldstein, C S Gerassimakis, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 27, 2011
Binding of Plasmodium merozoite proteins RON2 and AMA1 triggers commitment to invasionPrakash Srinivasan, Wandy L Beatty, Ababacar Diouf, et al.
JMIR Cancer|June 1, 2023
Engaging Men of Diverse Racial and Ethnic Groups With Advanced Prostate Cancer in the Design of an mHealth Diet and Exercise Intervention: Focus Group StudyElizabeth Y Wang, Hala T Borno, Samuel L Washington Iii, et al.
Cell|January 24, 2012
EMT and dissemination precede pancreatic tumor formationAndrew D Rhim, Emily T Mirek, Nicole M Aiello, et al.
Journal of Virology|February 10, 2017
A Murine Herpesvirus Closely Related to Ubiquitous Human Herpesviruses Causes T-Cell DepletionSwapneel J Patel, Guoyan Zhao, Vinay R Penna, et al.
Scientific Reports|January 31, 2026
Sequential platinum and PARP Inhibition enhances PD1 immunotherapy efficacy in murine Brca2 mutated pancreatic cancerJohn C McVey, Max M Wattenberg, Heather Coho, et al.
Cancer Immunology Research|May 4, 2022
Immunologic Features in De Novo and Recurrent Glioblastoma Are Associated with Survival OutcomesCécile Alanio, Zev A Binder, Renee B Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2023
Treatment Response in First-Line Metastatic Pancreatic Ductal Adenocarcinoma Is Stratified By a Composite Index of Tumor Proliferation and CD8 T-Cell InfiltrationGregory L Beatty, Devora Delman, Jiayi Yu, et al.
The Oncologist|September 26, 2022
Epacadostat Plus Pembrolizumab and Chemotherapy for Advanced Solid Tumors: Results from the Phase I/II ECHO-207/KEYNOTE-723 StudyJohn D Powderly, Samuel J Klempner, Aung Naing, et al.
Pageof 37